ARRIVE: Aspirin does not reduce initial vascular events in low-to-moderate risk population

ARRIVE: Aspirin does not reduce initial vascular events in low-to-moderate risk population  Healio Aspirin Fails to Prevent CV Events in People at 'Moderate' Risk of Disease: ARRIVE  TCTMD Aspirin Disappoints for Avoiding First Heart Attack, Stroke  U.S. News & World ReportFull coverage

(CLICK HERE TO READ AND SEE MORE)